4:00 PM SIGN-IN • 4:30 PM - 6:00 PM
BANDOL 1 (NEW WYNN SPACE)
CE: Inflammatory Bowel Disease: A Panel Discussion on Clinical and Operational Strategies for Biologic Usage
Inflammatory bowel disease (IBD) is a chronic, incurable illness comprising ulcerative colitis and Crohn disease. Goals of treatment in IBD include achieving and maintaining remission, which is often accomplished by pharmacologic treatment. Recent advancements have the potential to provide patients with new options to better control their symptoms and progression of the disease. The specialty pharmacist is ideally situated to work with patients and their providers to select and monitor safe, effective, and cost-effective therapies that improve quality of life and optimize patient outcomes. This expert panel discussion will highlight strategies for managing IBD as well as review recently approved agents, updated treatment guidelines, recent clinical trial data on biologics and biosimilars, and real-world data on how specialty pharmacists are helping to manage this complex disease.